Drawing for MARSHFIELD HEALTH

USPTO serial 87865119

MARSHFIELD HEALTH

Reviewed by CopyMark Law Group

Reg. 7176342Status 700Registered
Filing date
Status date
Registration date
Sep 26, 2023
Examiner
MCCARTHY, BRIDGET ANN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MARSHFIELD HEALTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Melinda S. Giftos

Melinda S. Giftos HUSCH BLACKWELL LLPPO BOX 137933 EAST MAIN STREET, SUITE 300MADISON, WI 53701-1379

Goods and services

ClassDescriptionStatusFirst use
009Computer programs and software for the collection, compilation, processing, transmission and dissemination of medical data and information for use in desktop, laptop, mobile and handheld electronic devices; downloadable electronic publications in the nature of brochures, articles, fact sheets and safety guidelines in the field of farm safety, health and medicineACTIVEJun 15, 2023
044Health care and medical services; providing information in the fields of health and medicine via global information networks; health care services; genetic testing for medical purposes and consultation thereof; medical testing for diagnostic or treatment purposes and consultation thereof; drug use testing services and consultation thereof; collection and preservation of human blood, bone marrow and progenitor cells, and consultation thereof; blood bank services and consultation thereof; medical testing of blood, bone marrow and progenitor cells for diagnostic or treatment purposes, and consultation thereof; health care and medical services; medical consultation; medical testing for diagnostic or treatment purposes; medical counseling; surgery; providing information about health and medicine via global computer information networks; providing medical, health and immunization information via the Internet; maintaining online personal medical, health and immunization history records and files; health maintenance services, namely, managed health care services; health care and medical services; medical consultation, medical testing for diagnostic or treatment purposes, and medical counseling; surgery; providing health information and conducting medical evaluations for patient triage, all provided to the public via telephone; nurse triage and call centers in the nature of conducting medical evaluations for patient triage and providing information regarding the identification of specific health related concerns and general health issues, all with nurse assistance via telephone; providing health care information by telephone; all of the foregoing services excluding services rendered to cystic fibrosis patients; providing health information; biobank services in the nature of collection and preservation of human blood and tissue samples; biobank services in the nature of providing access to human biological and tissue samples; health care services, namely, providing a database in the field of personalized medicine and genomics information and featuring inputting and collection of data and information all for research, treatment and diagnostic purposes; conducting telephone and in-person personal lifestyle wellness assessments; web-based personal lifestyle wellness assessments, namely, a series of health-related questions for response from the user that result in a report that provides health-related information; health care; Managed health care services; Medical services; Pediatric health care servicesACTIVEJun 15, 2023

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 26, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 26, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 19, 2023SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Aug 18, 2023CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jul 25, 2023SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jun 16, 2023IUAFUSE AMENDMENT FILED—
Jun 16, 2023EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Dec 28, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 27, 2022EX5GSOU EXTENSION 5 GRANTED—
Dec 27, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 9, 2022EXT5SOU EXTENSION 5 FILED—
Dec 9, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 8, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 6, 2022EX4GSOU EXTENSION 4 GRANTED—
Jun 6, 2022EXT4SOU EXTENSION 4 FILED—
Jun 6, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 22, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 20, 2021EX3GSOU EXTENSION 3 GRANTED—
Dec 20, 2021EXT3SOU EXTENSION 3 FILED—
Dec 20, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 18, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 16, 2021EX2GSOU EXTENSION 2 GRANTED—
Jun 16, 2021EXT2SOU EXTENSION 2 FILED—
Jun 16, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 18, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 16, 2020EX1GSOU EXTENSION 1 GRANTED—
Dec 16, 2020EXT1SOU EXTENSION 1 FILED—
Dec 16, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 23, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 28, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 28, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 8, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 23, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 13, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 13, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 12, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 12, 2019GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Sep 12, 2019GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Sep 12, 2019CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Aug 31, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 31, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 31, 2019ALIEASSIGNED TO LIE—
Aug 26, 2019ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Feb 26, 2019GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Feb 26, 2019GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 26, 2019CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 31, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 30, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 30, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 30, 2018GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jul 30, 2018GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jul 30, 2018CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jul 24, 2018DOCKASSIGNED TO EXAMINER—
Apr 13, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 9, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance